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One of the disadvantages of gel preparations is the poor ability to penetrate the skin. Herein we 
developed a sodium carboxymethylcellulose (NaCMC)-based gel containing microparticle of 
doxycycline hyclate (DOX).  Oleic acid (OA) was added into the gel formulation specifically to 
increase the penetrability of DOX microparticles. The objective of this work was to determine the 
effect of varying concentration of OA on the physical characteristics, penetration and retention 
abilities of DOX. DOX microparticles were initially prepared using PLGA as a matrix and then 
incorporated into a NaCMC-based gel with various OA concentrations: 0%, 2.5%, 5%, 7.5%, and 10% 
for F1, F2, F3, F4, and F5, respectively. The gel preparations were evaluated for their organoleptic 
test, homogeneity, pH measurement, viscosity, spreadability, as well as ex vivo penetration and 
retention abilities. The physical characteristics tests revealed a homogeneous yellow gel with a 
distinctive odor and pH values compatible with the pH requirements of human skin. The retention test 
showed the formulation retained 1236.46 µg of DOX in the skin. Finally, the skin retention of DOX 
from microparticles loaded gel was significantly higher compared to the free DOX loaded gel, 
indicating the microparticles can be extremely effective in retaining the DOX in the infected area. 
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Skin provides a physical protective barrier to the body against infections, the term of diseases 
caused by entry and development of microorganisms such as bacteria, fungi, parasites and viruses, 
which damage the skin thereby causing various clinical symptoms and signs (Chiller et al., 2001). 
Staphylococcus aureus is the most common bacteria causing chronic wound and soft tissue infections 
(Hatlen and Miller, 2021) . Infection is triggered by the presence of microorganisms that can penetrate 
the deeper skin layers of the dermis or subcutaneous tissue thereby damaging the tissue and impairing 
immune or healing response (Kalan and Femling, 2017). 
Doxycycline hyclate (DOX) is one of the antibiotics commonly used to treat skin infections 
(Smith et al., 2020). Doxycycline hyclate is reversibly bound to the 30S ribosomal subunits and 
prevents the formulation of peptide chains of amino acids, thereby inhibiting protein synthesis, with a 
broad spectrum of antibacterial properties and effective against P. aeruginosa and S. aureus 
(Chukwudi, 2016). According to (Borse et al., 2020), doxycycline hyclate showed an inhibition zone 
between 13.66 ± 1.69 mm to 32.00 ± 1.63 mm against S. aureus. 
Oral administration of DOX can cause side effects such as abdominal pain, gastrointestinal 
irritation and other side effects, whereas topical application can be more beneficial for the treatment 
and healing of bacterial wound infections (Smith et al., 2020). Topical antibiotics can minimize the 
side effects and local administration may hinder the potential for systemic absorption of antibiotics. 
This will subsequently reduce antibiotic resistance, act more selectively against the source of infection, 
and avoid first-pass metabolism (Marco et al., 2020). However, topical administration of a drug is 
usually limited to certain drug molecules, a factor which can hinder absorption of the drug by the 
infected skin (Kim et al.,2019). Stratum corneum, located in the outermost of epidermis, is considered 
to be the major barrier of drug absorption through the skin (Permana et al., 2020). Gels are one of the 
most commonly used topical preparations for use in treating skin infections. Gels can provide several 
advantages, as their easy formulation is relatively easy compared to other semisolid preparations, they 
are biocompatible, have a high skin retention time, high spreadability and a cooling effect on the 
application site (Nandini, 2009). 
However, the main drawback of gel preparation is poor drug penetration through the skin 
(Prakash et al., 2016) Hence, the addition of a skin penetration enhancer such as oleic acid is often 
considered necessary. Oleic acid is a mono-unsaturated fatty acid reported to increase the penetration 
of drugs through the skin. This compound acts by disrupting the densely arranged intercellular lipid 
domain of stratum corneum (Lengyel et al., 2019). However, when it reaches the dermal layer, DOX 
has a low retention ability, which means that doxycycline can quickly leave the dermis and enter the 
systemic circulation (Permana et al., 2020). For that reason, it is necessary to develop a drug delivery 
system and formulation to increase drug retention at the infection site and avoid systemic circulation. 
The use of microparticles is one option which has been studied as a drug delivery carrier for 
controlled release (Campos et al., 2013). Microparticles can be defined as particles possessing 
spherical shapes with sizes between 1 μm and 1000 μm, containing a mixture of active compounds and 
raw materials consisting of coatings attached to a matrix structure (Prow et al., 2011). It has been 
shown that the use of PLGA (poly lactic-co-glycolic acid) polymers can retain specific antimicrobial 
agents at the infected site, thereby reducing unwanted side effects leading to systemic issues. PLGA 
has several advantages including suitable degradation under physiological conditions and sustained 
drug release (Machado et al., 2013; Mazzara et al., 2019). Gel preparations contain gel bases which 
can be hydrophilic or hydrophobic (Patil et al., 2019). Carboxymethylcellulose sodium (NaCMC) is 
one of the gelling agents used in gel preparations at concentrations of 1-5%; it is a water-soluble 
cellulose derivative with good bioadhesive, biodegradability, biocompatibility and non-toxic 
properties (Akalin and Pulat, 2018). NaCMC is a polyelectrolyte that has varied ionic strength, 
sensitivity to pH, and can easily form a gel due to the presence of hydroxyl groups (Lopez et al., 
2018). This study aimed to formulate PLGA microparticles containing DOX with variations in the 
concentration of OA as a penetration enhancer in gel preparations. Following characterization of the 
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gel formulation, ex vivo permeation and retention trials were carried out to evaluate the ability of this 
approach to deliver DOX to the desired area. 
  
MATERIALS AND METHODS  
Chemicals and materials 
Doxycycline hyclate (DOX) (purity, ≥98%) was obtained from Alfa Aesar (UK). Sodium 
carboxymethylcellulose (NaCMC), PVA (9-10 kDa) and oleic acid (OA) were obtained from Sigma–
Aldrich (Singapore). All other reagents used were analytical grade. 
Formulation of DOX-loaded microparticles 
The incorporation of DOX into microparticle formulations was performed using double 
emulsion (W/O/W) solvent evaporation technique (Soomherun et al., 2017). Firstly, 250 mg of DOX 
was dissolved in 10 mL of distilled water. This solution was emulsified in a PLGA solution (500 mg in 
20 mL of dichloromethane) using a homogenizer at 3,000 rpm for 5 minutes, forming a W/O 
emulsion. This mixture was then emulsified in 50 mL PVA (9-10 kDa) solution in water (2% w/v) 
using a homogenizer at 3,000 rpm for 10 minutes, creating a W/O/W emulsion. In order to evaporate 
the solvent and form the microparticles, the double emulsion was stirred at room temperature for 8 h. 
The microparticles were finally collected following three washing steps with distilled water using 
centrifugation at 2,000 rpm for 15 min to remove the unencapsulated DOX and PVA.  
The particle size and polydispersity index of the microparticles were observed using a light 
microscope. The encapsulation efficiency (EE) of DOX in the microparticles was determined through 
an indirect technique (Soomherun et al., 2017). After the first centrifugation in the washing steps, the 
supernatant containing free DOX was subjected to UV-Visible spectrophotometry. The EE of DOX in 
the microparticles was determined using equation (1). 
 
EE (%) =  X  (1) 
Preparation of gel containing DOX microparticles  
Gels were prepared using NaCMC and oleic acid as a gelling agent and as a penetration 
enhancer, respectively. Additionally, glycerin was used as a humectant and DMDM hydantion was 
used as preservative. The compositions of each formulation are shown in Table 1. NaCMC aliquots 
were weighed accurately and dissolved in warm water (temperature 70
o
C) in a beaker, then 
homogenized at 2,000 rpm for 10 minutes until a colloidal solution was formed. Glycerin was added to 
the solution, then DOX microparticles were added to the solution which was then stirred. Once the mix 
was homogeneous, OA was mixed into the solution and DMDM hydantoin was added to the solution 
which was then stirred and homogenized at 1,000 rpm for 15 minutes to form a gel. 
Table 1. Composition of gel formulations containing DOX microparticles (%w/w) 
Composition DOX 
Microparticles  
NaCMC Glycerin Oleic acid DMDM 
Hydantoin 
Water 
F1 2.5 5 10 - 0.1 until 100 
F2 2.5 5 10 2.5 0.1 until 100 
F3 2.5 5 10 5 0.1 until 100 
F4 2.5 5 10 7.5 0.1 until 100 
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Organoleptic observations were carried out by visually or directly observing the color, smell, 
and appearance of the gel preparations (Ardana et al., 2015). 
 
Homogeneity test 
The homogeneity test was carried out by applying the gel preparation to a piece of glass or other 
suitable transparent material, then observing the homogeneity of the preparation (Borse et al., 2020). 
  
pH measurement 
The pH measurement of the resulting gel preparations was performed using a calibrated digital 
pH meter. The procedure was repeated three times and the pH meter readings were recorded. Results 
were compared to the target pH for skin application, which is 4.5-6.5 (Borse et al., 2020). 
 
Viscosity test 
The viscosity of the gel preparations was measured using a Brookfield Viscometer by dipping 
the Spindle 6 into the gel preparation at a speed of 50 rpm. The procedure was repeated three times for 
each preparation and the mean viscosity was recorded in centipoise units (cPs) (Permana et al., 2020).  
 
Spreadability test 
Gel spreadability was measured by placing 1 gram of gel preparation between two glass plates 
measuring 20 x 20 cm, then pressing them together horizontally. Weights were then placed on top of 
the glass plates for 1 minute each, with a sequence of 125, 225, 325, 425 and 525 g. The diameter of 
the gel dispersion was measured using a caliper (precision 0.15 mm). The procedure was repeated 
three times for each preparation and the results obtained were the mean of these three replicates 
(Permana et al., 2020).  
 
In vitro skin occlusivity 
Investigation of in vitro skin occlusivity was performed according to (Cohen-Sela et al., 2009). 
Initially, 250 mg of each gel formulation was weighed and applied to a Whatman 2.5 µm filter paper. 
Water (50 mL) was placed in a 100 mL beaker and covered with the filter paper containing the gel 
formulation. A filter paper without formulation was utilized as a control. The beakers were placed in 
an oven at 32°C. At predetermined times (0, 6, 24 and 48 h), the weight of the system was calculated. 
Finally, the occulisivity (F0) was calculated using the following equation (2): 
F0 =  (2) 
where, W0 is the water loss of the control and W1 is the water loss of the gel formulation 
 
Effect of gel formulation on microparticles size and PdI 
After dispersing the gel preparations in distilled water, the mixture was centrifuged at 2,000 rpm 
for 15 minutes and washed three times with water. The pellets were resuspended with water and then 
microparticle size and PDI were calculated. 
 
Ex vivo dermal delivery  
The gel preparations were evaluated for their ex vivo dermal delivery of the gel using a Franz 
diffusion cell. In this study, phosphate buffer saline (PBS) (pH 7.4) was used as the medium. Initially, 
rat abdominal skin was dissected, and the remaining hairs were trimmed. Then, prior to each 
experiment, skins were soaked in PBS. PBS was filled into the receptor section, and the skin was 
attached in Franz diffusion cell. The evaluation was conducted at 37±0.5 °C with constant stirring at 
100 rpm. An aliquot of 1 gram of gel (equivalent to 10 mg of DOX) was spread uniformly on the 
Pharmaciana ISSN: 2088 4559; e-ISSN: 2477 0256  
 






surface of skin in the donor compartment. Samples were taken (1.5 mL) at various intervals in time, 
and the volume taken was replaced with the same volume of PBS pH 7.4 at the same temperature. 
Sample content was examined through UV-Visible spectrophotometry, the drug concentration in the 
sample was determined using a standard curve, then the rate of release (penetration flux) of the 
preparation was calculated. The penetration flux (J) was calculated using following equation (3): 
 
J =  (3) 
where, M is the cumulative total of sample passing through the membrane (µg), S is diffusion area width (cm), 
and T is time (h) 
 
Retention test 
The rat skin used in the permeation test was placed in 50 mL of PBS pH 7.4 solution and the 
mixture was homogenized at 1,000 rpm for 15 minutes. The supernatant was collected and centrifuged 




All results were reported as mean ± standard deviation (SD) of the mean. Data were tabulated 
(including mean and SD calculations) in Microsoft® Excel® 2013 (Microsoft Corporation, Redmond, 
USA). Statistical analyses were implemented in GraphPad Prism® version 5 (GraphPad Software, San 
Diego, California, USA). In all cases, significance was determined at the 95% confidence level (p < 
0.05). 
 
RESULT AND DISCUSSION 
Formulation of DOX-loaded microparticles 
PLGA microparticles containing DOX were formulated using a multiple emulsion technique. 
This technique is suitable for loading hydrophilic drugs, like DOX, into hydrophobic PLGA 
microparticles (Cohen-Sela et al., 2009). Microparticle diameter was 2.98 ± 0.21 µm with a PDI value 
of 0.281 ± 0.03. With respect to the EE value, due to hydrophilicity, approximately 40.32 ± 0.04% 
DOX was encapsulated in the PLGA microparticles. Considering the EE values of DOX, to achieve a 
concentration of 1% w/v DOX in the gel formulation, 2.5% DOX microparticles were incorporated 
into the NaCMC-based gel formulation with various OA concentrations: F1 (0%), F2 (2.5%), F3 (5%), 
F4 (7.5%) and F5 (10%). 
 
Gel characteristics 
Organoleptic and homogeneity  
Based on organoleptic test results presented in Figure 1a, all tested formulations had similar 
physical characteristics. All the formulations were colorless to yellowish white, and had a distinctive 
smell. The homogeneity evaluation (Figure 1b) showed that all gel preparations had good homogeneity 
with none exhibiting grittiness or coarse granules. Based on these results, all formulations were 
evaluated further. 
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Figure 1 (a) Physical aspect of doxycycline microparticle gel preparations with 
various oleic acid concentrations: F1 (0%), F2 (2.5%), F3 (5%), F4 
(7.5%) and F5 (10%); (b) Homogeneity tests results for the doxycyline 
microparticle gel preprations 
pH and viscosity 
 The pH of the gel preparations was measured as it is crucial to develop to develop formulations 
with specific pH values appropriate for topical preparations to avoid irritation of the skin (Wohlrab 
and Gebert, 2018). The pH values of the DOX microparticle gels ranged from 5.51 to 5.91 (Table 1). 
The widely accepted ideal pH range for skin treatments is pH 4.5 - 6.5 (Ali and Yosipovitch, 2013). 
These results indicate that all formulations met the gel skin criteria requirement, and would be unlikely 
to produce skin irritation.   
Viscosity is a descriptor of preparations which influences the characteristics of the gel 
preparation at the time of application, including consistency, spreadability and moisture content, as 
well as drug release. The viscosity of the DOX microparticle gels ranged from 36,933 to 46,766 cPs 
(Table 2). The desired viscosity for gel preparations is in the range of 10,000 – 100,000 cPs (Malik 
and Kaur, 2018). The viscosity test results show that increasing OA concentration improved the 
viscosity of the preparation, with all formulations (F1 to F5) within the appropriate range for gel 
preparations. 
Table 2. pH and viscosity of doxycycline microparticle gel preparations with various 




pH values Viscosity values 
F1 0% 5.91 ± 0.02 46,766 ± 1101 
F2 2.5% 5.86 ± 0.02 42,233 ± 1514 
F3 5% 5.82 ± 0.02 39,866 ± 650 
F4 7.5% 5.73 ± 0.01 37,866 ± 650 
F5 10% 5.52 ± 0.04 36.933 ± 152 
 
Spreadability and in vitro skin occlusivity 
The spreadability test evaluated the ability of the gel preparations to spread and become 
distributed when applied to the skin. For all formulations, the greater the load applied, the greater the 
gel spread. The spreadability test results (Table 3) were inversely proportional to the viscosity 
measurements, with increasing OA concentration reducing spreadability. According to (Nitalikar and 
Sakarkar, 2013) the spreadability range for semi solid preparations is 3-5 cm diameter. The 
spreadability of all the formulations (F1, F2, F3, F4 and F5) was within the desired 3 - 5 cm diameter 
range.   
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Evaluation of skin occlusivity was performed in vitro to envisage the ability of the gel 
formulation to preserve the hydration profile of the skin (Wavikar and Vavia, 2013). Higher gel 
formulation occlusivity could hypothetically enhance skin hydration for 48 hours, thus permitting drug 
penetration into the deeper layers of the skin due to a decrease in corneocyte gaps (Purnamawati et al., 
2017). The in vitro skin occlusivity results (Table 2) show that the addition of OA increased the 
occlusivity of all gel formulations. The difference between the OA formulations (F2 to F5) and the 
control (F1) was statistically significant (p < 0.05).  
 
Table 3. Spreadability and in vitro skin occlusivity of doxycycline (DOX) 
microparticle gel preparations with various oleic acid concentrations:. 
(n=3, mean ± SD) 




F1 0% 3.71 ± 0.72 84.01 ± 8.52 
F2 2.5% 3.98 ± 0.71 84.93 ± 8.58 
F3 5% 4.23 ± 0.75 86.32 ±8.42 
F4 7.5% 4.59 ± 0.84 86.35 ± 8.64 
F5 10% 4.78 ± 0.85 87.42 ± 8.52 
 
Effect of gel formulation on microparticle size and PdI  
It is important to note that the incorporation of microparticles did not change the characteristics 
of the microparticles, particularly size and PdI. It was observed the particle size and PDI values of 
DOX-loaded microparticles were 3.11 ± 0.24 µm and 0.218 ± 0.03 µm, respectively. These values 
were not significantly different (p > 0.05) from the initial characteristics of the microparticles. 
Therefore, the incorporation of the microparticles into the gel formulation did not affect the size and 
PdI of the DOX-loaded microparticles. This result agreed to previous finding in which it is reported 
that incorporation of microparticles into gel base did not alter their physical characteristics (Souto et 
al., 2004). 
 
Ex vivo dermal delivery 
In an attempt to determine the amount of DOX microparticles from the gel preparation that 
could penetrate through the skin during a certain time interval, ex vivo dermal delivery studies were 
carried out. The trial results for ex vivo DOX microparticle penetration through the skin (Figure 2a) 
show that the control (F1) without OA as penetration enhancer was unable to penetrate through the 
skin after 24 h, as DOX microparticles were unable to penetrate the SC, while increasing the 
concentration of OA increased ability of DOX microparticles to permeate the skin layer, thus 
increasing the amount of drug which could be delivered to the site. This role of OA as a penetration 
enhancing compound acts by disordering the densely arranged stratum corneum intercellular lipid 
domain. In this study, gel formulation containing DOX without microparticle was prepared and used 
and control the ex vivo dermal delivery evaluation. The result showed that after 24 h, 8739 ± 783 µg of 
DOX was delivered when DOX was not formulated into microparticles. Therefore, our approach 
indicated that the formulation of DOX into microparticles could avoid undesired systemic exposure of 
DOX. 
To evaluate the release rate of doxycycline microparticles from the gel preparation, flux 
calculations (Figure 2b) show that release rate of doxycycline microparticles from the gel increased 
over time, and was positively associated with OA concentration. The penetration flux can be affected 
by several factors, one of which is microparticle size. The smaller the particle size, the higher the 
amount of drug that interacts with the area in SC (Adib et al., 2016). Another is OA concentration, 
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with the results confirming that the addition of a suitable concentration of OA to a gel preparation can 
act as a penetration enhancer and can thereby increase the release rate of an active ingredient.  
Permeation data did not fully support the desired local effect because the permeation test was 
carried out to determine the amount of drug that could penetrate through the skin, whereas to achieve a 
local effect it is necessary to know the amount of DOX microparticles that could be left on the skin. 
The purpose of this test was to determine the amount of DOX deposited on the skin. The DOX 
microparticle retention test (Figure 2c) shows lower amounts of DOX deposited by formulations F1 
and F2 (OA concentrations 0% and 2.5%) and were not significantly different from each other (p> 
0.05), indicating that these formulations have a low retention capability in the skin. F3 (5% OA) was 
significantly different (p <0.05) from F4 and F5, with less DOX deposited. The F5 formulation (10% 
OA) had the highest DOX penetration but showed significantly lower DOX retention than F4 (7.5% 
OA). This high retention time indicates that F4 could have a longer lasting local effect on the skin. 
This could be explained by the way in which the PLGA-based polymer microparticle delivery system 
absorbs medicinal raw materials to heal skin wounds or disease and then controls their release (Han et 
al., 2016). 
Interestingly, F5 formulation which contained the highest (10%) OA concentration was the most 
effective in terms of enhanced penetration with the highest rate of dermal delivery, but also had a 
lower skin retention than F4 (7.5%), most likely due to the drug swiftly reaching the systemic 
circulation and thereby reducing the desired local effect (Santoyo and Gartua, 2000) One important 
goal of the dermal drug delivery system is to maximize the amount of drug that enters the skin layer, 
thereby increasing the retention time of the drug in the skin. However, several other factors may 
contribute to the retention profile, including the partition of the drug through the skin layers. (Banning 
and Heard, 2002) reported that DOX has relatively high affinity to keratin which may attribute to its 
skin permeation profile as well. In this case, F4 with 7.5% OA was shown to promote enhanced skin 
permeation, while providing sufficient drug retention in skin layers.  
 
 
Figure 2. Skin penetration performance of doxycycline (DOX) microparticle gel 
preparations with various OA concentrations: F1 (0%), F2 (2.5%), F3 
(5%), F4 (7.5%) and F5 (10%): (a) dermal delivery; (b) flux penetration; 
(c) retention test. Control in the permeation study indicated the 
formulation without microparticle formulation 
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This study demonstrated that varying the concentration of oleic acid (OA) as penetration 
enhancer in gel preparations affects the physical characteristics, skin penetration, and retention time of 
a PLGA-based polymer microparticle drug delivery system. The highest OA formulation (10%) 
enabled the highest amount of the drug to penetrate the skin, while the highest drug retention was 
obtained with the 7.5% OA formulation. 
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